Who are Freezed-dried plasma's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pathogen-Reduced Cryoprecipitate, FFP and Cryoprecipitate, FFP/Cryo.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/freezed-dried-plasma.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Freezed-dried plasma — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Freezed-dried plasma (Freezed-dried plasma) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Blood product / Hemostatic agent. Area: Hematology / Hemostasis.

phase 3 Blood product / Hemostatic agent Hematology / Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Freezed-dried plasma (Freezed-dried plasma) — University Hospital, Lille. Freeze-dried plasma reconstitutes fresh frozen plasma to restore coagulation factors and hemostatic function in patients with bleeding or coagulopathy.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Freezed-dried plasma TARGET	Freezed-dried plasma	University Hospital, Lille	phase 3	Blood product / Hemostatic agent
Pathogen-Reduced Cryoprecipitate	Pathogen-Reduced Cryoprecipitate	Weill Medical College of Cornell University	marketed	Blood product / Hemostatic agent
FFP and Cryoprecipitate	FFP and Cryoprecipitate	The University of Texas Health Science Center, Houston	marketed	Blood product / Hemostatic agent
FFP/Cryo	FFP/Cryo	Biotest	phase 3	Blood product / Hemostatic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Blood product / Hemostatic agent class)

Biotest · 1 drug in this class
The University of Texas Health Science Center, Houston · 1 drug in this class
University Hospital, Lille · 1 drug in this class
Weill Medical College of Cornell University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Freezed-dried plasma — Competitive Intelligence Brief. https://druglandscape.com/ci/freezed-dried-plasma. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing